Leonard S. Schleifer, President & CEO at REGENERON PHARMACEUTICALS INC (REGN), sold 150,954 shares at $175.13 ($16.1M) on 2013-03-07, disclosed to the SEC on 2013-03-07.
Scheduled sale ($16.1M) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 59,271 | $0 | 0.0% |
| 2 | $175.21 | 19,146 | $3.4M | 20.9% |
| 3 | $175.28 | 60,803 | $10.7M | 66.3% |
| 4 | $176.10 | 8,200 | $1.4M | 9.0% |
| 5 | $175.13 | 3,534 | $619K | 3.9% |
| Total | $106.49 avg | 150,954 |
| $16.1M |
| 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |